International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer

Nicoletta Colombo, David Guthrie, Stefania Chiari, Mahesh Parmar, Wendi Qian, Ann Marie Swart, Valter Torri, Christopher Williams, Andrea Lissoni, Cristina Bonazzi, International Collaborative Ovarian Neoplasm (ICON) collaborators

Research output: Contribution to journalArticlepeer-review

222 Citations (Scopus)

Abstract

The question of whether platinum-based adjuvant chemotherapy can improve outcomes in patients with early-stage epithelial ovarian cancer is an important one. We carried out a multicenter, open randomized trial to determine whether adjuvant chemotherapy would improve overall survival and prolong recurrence-free survival in women with early-stage epithelial ovarian cancer.
Original languageEnglish
Pages (from-to)125-32
Number of pages8
JournalJournal of the National Cancer Institute
Volume95
Issue number2
Publication statusPublished - 15 Jan 2003

Keywords

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Carboplatin
  • Carcinoma
  • Chemotherapy, Adjuvant
  • Cisplatin
  • Confidence Intervals
  • Disease-Free Survival
  • Drug Administration Schedule
  • Female
  • Humans
  • International Cooperation
  • Middle Aged
  • Neoplasm Staging
  • Observation
  • Odds Ratio
  • Ovarian Neoplasms
  • Survival Analysis
  • Treatment Outcome

Cite this